Results 11 to 20 of about 12,541 (204)
Papilledema Due to Mirtazapine
Background: Mirtazapine is a tetracyclic antidepressant that enhances both noradrenergic and serotonergic transmission. The most common cause of papilledema is increased intracranial pressure due to brain tumor.
Mehmet Emin Ceylan+2 more
doaj +5 more sources
Bilateral Papilledema in Hypocalcemia
Papilledema is a rare but recognized complication of hypocalcaemia with primary or surgically induced hypoparathyroidism. We report a case with primary hypocalcaemia who presented with bilateral cataract with Papilledema as the first clinical ...
JL Goyal+5 more
doaj +4 more sources
Diclofenac-induced papilledema
A 32-year-old female came to the outpatient with complaints of headache. She was taking tablet diclofenac over the counter for the same without proper prescription from the doctor. On examination, anterior segment appeared normal with vision in both eyes
Abhinay Ashok+2 more
doaj +2 more sources
Jerome B. Balbin, Riddhi Desai
doaj +3 more sources
Signs of Intracranial Hypertension in Chronic Inflammatory Polyradiculoneuropathies-A Cross Sectional Cohort Study. [PDF]
This prospective cross‐sectional study screened 27 patients with inflammatory polyradiculoneuropathy (IPN) for signs of intracranial hypertension (IH) using multimodal ophthalmological assessments (fundoscopy, perimetry, OCT, ultrasonography). Signs of IH were identified in 37% of patients.
Macher S+13 more
europepmc +2 more sources
Papilledema or pseudopapilledema?
Lin Liu, Michael D Yu, Carol L Shields
doaj +4 more sources
Papilledema as the Sole Manifestation of Neuroborreliosis [PDF]
Lyme disease is reportable, and approximately 30,000 cases/year are notified to the local and state health departments. However, other estimates based on insurance records suggest there are close to 476,000 cases/year that are diagnosed and treated. In addition to a large burden of illness, areas where Lyme disease is common are expanding.
Kaitlyn E. May, Shankar Upadhyayula
openalex +5 more sources
Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis. [PDF]
ABSTRACT Introduction/Aims Tofersen is approved for the treatment of amyotrophic lateral sclerosis (ALS) due to superoxide dismutase 1 mutations (SOD1‐ALS). Here we report serious neurologic adverse events (AEs) that occurred in the tofersen clinical trials in people with SOD1‐ALS.
Lovett A+17 more
europepmc +2 more sources
PURPOSE: The purpose of this study was to evaluate whether papilledema severity is associated with specific demographic or clinical factors in patients with idiopathic intracranial hypertension (IIH).
Jonathan A Micieli+5 more
doaj +1 more source
Papilledema Associated with Puberty [PDF]
research-article2014 CPJXXX10.1177/0009922814554503Clinical PediatricsSun and Horton Resident Round Papilledema Associated with Puberty Clinical Pediatrics 2015, Vol. 54(5) 504–506 © The Author(s) 2014 Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/0009922814554503 cpj.sagepub.com Lynn W.
Sun, Lynn W, Horton, Jonathan C
openaire +5 more sources